Posts Tagged qd syringes

QD Syringe | How to Luer on the QD Hub and Needle

Thursday, October 20th, 2016 | Permalink

qd-syringe-how-to-luer-on-the-low-residual-volume-qd-hub-and-needle

QD Syringe – QD Hubs and Needles

QD Syringes are the next generation of basic disposable plastic syringes with detachable injection hubs with needles. The QD Syringe does not need a detachable draw needle to draw fluid inside of its barrel. The QD Syringe has an integrated BPA free acrylic tip with GlyFlo Technology to accomplish this task. The QD Syringe is a low dead space syringe and has the sharpest needles of any injection syringe available.

The QD Syringe works by being functional right out of it’s package. It is the only syringe that is able to draw fluid into itself. Then the appropriate steel needle gauge and length is attached over it’s tip and a virtually painless injection is given.

The painless injection is accomplished by not using the sharp steel needle to draw up medications and dulling its tip prior to giving the patient injection. The QD Syringe gives IV push injections and is also compatible with a majority of pre-slit injection receptacles such as the BD Q-Syte. All of this is accomplished by the low dead space QD Syringe. The QD Syringe is a BPA Free Medical Syringe. Coming Soon: The QD Neutral Displacement Needleless Connector which will be compatible with the QD Syringe and standard luer lock syringes.

www.QDSyringe.com

www.Syringes.co

www.QDSyringeSystems.com

QD Syringe | QD Syringe Systems | BPA Free Low Dead Space Syringe

Tuesday, October 4th, 2016 | Permalink

qd-syringe-qd-syringe-systems-quick-draw-syringe

A New Syringe Designed for greater Dose Control ~ The patented design of the QD Syringe includes several innovative concepts that also help make it one of the most versatile syringe products available. The QD Syringe consists of a patented BPA Free cone tip with GlyFlo™ Technology designed as a ready to use draw down needle, eliminating time, needle dulling, hazardous waste and additional inventory ~ Unique bilateral fluid flow channels for easy draw and delivery of viscous liquids ~The QD Syringe is compatible with existing Luer Lock Hubs ~ The QD Syringe has a low dead space mating needle Hub available for up to 20 needle gauge sizes. The QD Syringe is a BPA free medical device.

For More information contact: Christopher Green and Nicholas J. Sears, M.D., FACS at: QuickDrawSyringe@gmail.com
www.QDSyringe.com
www.QDSyringeSystems.com

www.Syringes.co

 

——————————————

What Are Low “Dead Space” Syringes?

Wednesday, February 1st, 2012 | Permalink

Another guest article from Jamie Bridge this week. This time he’s writing about some of the work of researcher Dr. William Zule, looking into how the type of syringe someone uses may have an inpact on their risk of getting the HIV virus. I have had this article a few weeks but it was embargoed until the AIDS2010 conference started as its finding are being presented there.

How syringe type effects HIV risk

New research being presented this week at the International AIDS Conference in Vienna has made a strong link between different types of syringe and levels of HIV transmission through sharing.

Every needle-syringe, when the plunger is fully depressed, retains some fluid or blood in what is termed “dead-space”. Some syringe designs have more of this “dead space” than others – especially those with detachable needles. Depending on the design, some syringes can retain 84 microlitres of fluid. This is a very, very small amount – but other syringe designs can retain as little as 2 microlitres.

So the hypothesis is simple: if you share a syringe with higher “dead-space”, then there will be more blood retained in the syringe and you will be more likely to become infected with blood-borne viruses. If you share a low “dead space” syringe, you are still putting yourself at risk – but perhaps less so, as there is less blood retained when the plunger is fully down.

Previous modelling work by Dr William Zule and colleagues in the USA tried to quantify what this could mean in the real world. The results suggested that injection-related HIV epidemics might not occur when most (95% or more) of injectors use syringes with low “dead space”. If everyone uses higher “dead space” syringes, then HIV prevalence can reach 50% among injectors in just seventeen years. When just one in ten sharing events involve high “dead space” syringes, then HIV prevalence can stabilise.

The findings, albeit theoretical, have clear implications for harm reduction programs. However, in Vienna, the research has been taken to the next level. Data from multi-year HIV prevalence studies were gathered from 35 cities in 20 countries, and local needle exchange workers were contacted to find out what types of syringe were mainly used.

In cities where high “dead space” syringes were mainly used, the average HIV prevalence among injectors was 32.6% (and went up as high as 73%). In cities where low “dead space” syringes were mainly used, the average was just 1.4%. When the data were analysed, the type of syringe was the only factor closely associated with this pattern in HIV.

More research needs to be done on this topic, and expect to hear a lot more about this in the future – this is an important finding which could have a big impact on harm reduction and the advice given to injectors. Of course, the biggest message is that ALL needle-syringe sharing is a risk. However, if we could reduce HIV transmission simply by providing one kind of syringe over another, then this is something that must be rolled out as soon as possible. Do you know what kind of syringe your local exchange supplies?

A big thank you to Dr William Zule for sharing this research.

 

Jamie Bridge, MSc, currently works in the Technical Publications and Learning Team of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Before moving to Geneva in 2010, he worked for the International Harm Reduction Association in London, coordinating the international harm reduction conferences. Before that, he also worked in a needle and syringe program in Bedford. Jamie also works voluntarily with UKHRA and the NNEF.

——-

www.QDSS.co

www.QDSyringeSystems.com

www.SafetySyringe.cc

 

Congressional Letter Urges FDA to Improve Med Tech Pathway

Monday, January 30th, 2012 | Permalink

Congressional Letter Urges FDA to Improve Med Tech Pathway

11/08/2011

A bipartisan, bicameral letter was sent to FDA Commissioner Margaret Hamburg recently urging her to improve the agency’s handling of medical technologies. “Unless we make significant improvements to the predictability and transparency of the regulatory process, we will lose the industry, the jobs that go with it, and the innovation to transform our healthcare system,” stated the letter.

The signers are asking FDA to:

  • Recognize and correct the disparity between “FDA time” versus real time when tracking device approvals;
  • Consider potential benefits of harmonization with international testing standards;
  • Address the unintended consequences of the conflict of interest rules for advisory panels; and,
  • Create a transparent tracking and review system for applications and clearance decisions.

A hearing will be held in the U.S. Senate next week taking a closer look at efforts FDA is working on to improve the regulatory environment,  and examining the impact that today’s challenges are having on patient care and innovation.

http://www.medicaldevices.org/node/1118

~ QD Syringe Systems

See the original post:
Congressional Letter Urges FDA to Improve Med Tech Pathway